Literature DB >> 7059344

Reduction in glutathione content of L-PAM resistant L1210 Cells confers drug sensitivity.

K Suzukake, B J Petro, D T Vistica.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7059344     DOI： 10.1016/0006-2952(82)90249-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  26 in total

1.  Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins.

Authors:  J T Safrit; B Bonavida
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 2.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Glutathione content and gamma-glutamyltranspeptidase activity in squamous cell head and neck cancer xenografts.

Authors:  H Bier; W Bergler; S Mende; U Ganzer
Journal:  Arch Otorhinolaryngol       Date:  1988

4.  Effect of selenium compounds and thiols on human mammary tumor cells.

Authors:  L Yan; J A Yee; L M Boylan; J E Spallholz
Journal:  Biol Trace Elem Res       Date:  1991-08       Impact factor: 3.738

5.  Alkylating agent resistance: in vitro studies with human cell lines.

Authors:  E Frei; C A Cucchi; A Rosowsky; R Tantravahi; S Bernal; T J Ervin; R M Ruprecht; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

6.  Sensitization of human melanoma cells to melphalan cytotoxicity by adriamycin and carmustine.

Authors:  V Jevtović-Todorović; T M Guenthner; V Jevtorić-Todorović
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 7.  Regional treatment strategies for in-transit melanoma metastasis.

Authors:  Ryan S Turley; Amanda K Raymond; Douglas S Tyler
Journal:  Surg Oncol Clin N Am       Date:  2011-01       Impact factor: 3.495

8.  Development of a model of melphalan-induced gastrointestinal toxicity in mice.

Authors:  S Castellino; G B Elion; O W Griffith; M Dewhirst; J Kurtzberg; R C Cattley; P Scott; D D Bigner; H S Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.

Authors:  W R Waud; J Plowman; S D Harrison; D J Dykes; W K Anderson; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 10.  Optimizing regional infusion treatment strategies for melanoma of the extremities.

Authors:  Andrew Coleman; Christina K Augustine; Georgia Beasley; Gretchen Sanders; Douglas Tyler
Journal:  Expert Rev Anticancer Ther       Date:  2009-11       Impact factor: 4.512
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.